Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on the Mechanism s of Berberine Improving Cognitive Impairments in Schizophrenia Based on Gut-brain Axis

NCT07359209 is registered in ClinicalTrials.gov with Tianjin Anding Hospital as lead sponsor.

NCT NCT07359209
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07359209 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on the Mechanism s of Berberine Improving Cognitive Impairments in Schizophrenia Based on Gut-brain Axis
Lead sponsor
Tianjin Anding Hospital
Phase
Not applicable
Overall status
Completed
Start date
July 21, 2023
Completion date
April 23, 2026
Enrollment
124 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia therapeutics